← Eichor
Condition: Pulmonary Cystic Fibrosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pulmonary Cystic Fibrosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulato
Phase 3 · 1 location(s) · Indiana University · NCT06996951Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
NA · 33 location(s) · University of Washington, the Collaborative Health Studies C · NCT0665475219F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease
Phase N/A · 1 location(s) · University of North Carolina, Chapel Hill · NCT06066723Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor
NA · 15 location(s) · University Hospital, Bordeaux · NCT05937815A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants Wi
Phase 2 · 23 location(s) · ReCode Therapeutics · NCT06237335Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants
Phase 1 · 1 location(s) · Vertex Pharmaceuticals Incorporated · NCT07283770Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection
Phase 1 · 2 location(s) · Ghady Haidar · NCT07275905Genetics of Insulin and Incretins in Cystic Fibrosis
Phase N/A · 2 location(s) · Children's Hospital of Philadelphia · NCT01852448Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
Phase N/A · 1 location(s) · University of Kansas Medical Center · NCT06985225Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome
Phase N/A · 1 location(s) · Bettina Mittendorfer · NCT070835574D-710 in Adult Patients With Cystic Fibrosis
Phase 2 · 20 location(s) · 4D Molecular Therapeutics · NCT05248230Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants
Phase 1 · 1 location(s) · Vertex Pharmaceuticals Incorporated · NCT07437105Beta-cell Response to Incretin Hormones in Cystic Fibrosis
NA · 1 location(s) · University of Pennsylvania · NCT01851694Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Phase 2 · 1 location(s) · University of Kansas Medical Center · NCT06364176Physical Impairments in Children With Cystic Fibrosis
Phase N/A · 1 location(s) · Izmir Democracy University · NCT06984679The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program
NA · 1 location(s) · Rakitzi, Stavroula · NCT07255131A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of
NA · 1 location(s) · Ad scientiam · NCT06132048Circadian Rhythm Disorders in Children With Cystic Fibrosis Under CFTR (Cystic Fibrosis Transmembrane Conductance Regula
Phase N/A · 3 location(s) · Hospices Civils de Lyon · NCT06370962Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Phase 2 · 13 location(s) · Arcturus Therapeutics, Inc. · NCT06747858ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
Phase N/A · 1 location(s) · iSono Health, Inc. · NCT07505797NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05017766GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Phase 2 · 2 location(s) · University of Pennsylvania · NCT04731272Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis
EARLY_Phase 1 · 1 location(s) · University of Nottingham · NCT07569419Remote Sputum Collection in Cystic Fibrosis
Phase N/A · 3 location(s) · University of Pennsylvania · NCT06950892Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
NA · 1 location(s) · Hôpital Necker-Enfants Malades · NCT02965326Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease
Phase 2 · 1 location(s) · The Hospital for Sick Children · NCT02740868Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Phase 4 · 60 location(s) · Chris Goss · NCT05548283COVID-19 Antibody Responses In Cystic Fibrosis
Phase N/A · 1 location(s) · Pilar Azevedo · NCT06274840Trikafta Exercise Study in Cystic Fibrosis
Phase N/A · 1 location(s) · University of British Columbia · NCT05279040A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Phase N/A · 68 location(s) · Nicole Hamblett · NCT06504589
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.